MedTrace Logo

Metformin Use to Improve Pregnancy Outcome in Women With Type 1 Diabetes.

NCT03765359 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2023-06-07

No results posted yet for this study

Summary

The study investigates whether additional metformin medication in combination with regular insulin treatment will decrease the need of insulin for women with diabetes mellitus type 1 during pregnancy.

Conditions

Interventions

DRUG

metforminhydrochloride

metformin 500 mg tablets and insulin

DRUG

Placebo Oral Tablet

Placebo tablets mimic metformin 500 mg tablets and insulin

Sponsors & Collaborators

  • Turku University Hospital

    collaborator OTHER_GOV

  • Oulu University Hospital

    collaborator OTHER

  • Helsinki University Central Hospital

    collaborator OTHER

  • Central Finland Hospital District

    collaborator OTHER

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Kati Tihtonen, PhD · Tampere University Hospital, Tampere University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-05
Primary Completion
2022-12-19
Completion
2022-12-19

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03765359 on ClinicalTrials.gov